Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study

European Heart Journal

13 January 2025
Organised by: Logo
ESC Journals Public Health and Health Economics Research Methodology HEART FAILURE Acute Heart Failure Chronic Heart Failure PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Abstract

AbstractBackground and Aims

Current heart failure (HF) risk stratification strategies require comprehensive clinical evaluation. In this study, artificial intelligence (AI) applied to electrocardiogram (ECG) images was examined as a strategy to predict HF risk.

Methods

Across multinational cohorts in the Yale New Haven Health System (YNHHS), UK Biobank (UKB), and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), individuals without baseline HF were followed for the first HF hospitalization. An AI-ECG model that defines cross-sectional left ventricular systolic dysfunction from 12-lead ECG images was used, and its association with incident HF was evaluated. Discrimination was assessed using Harrell’s C-statistic. Pooled cohort equations to prevent HF (PCP-HF) were used as a comparator.

Results

Among 231 285 YNHHS patients, 4472 had primary HF hospitalizations over 4.5 years (inter-quartile range 2.5–6.6). In UKB and ELSA-Brasil, among 42 141 and 13 454 people, 46 and 31 developed HF over 3.1 (2.1–4.5) and 4.2 (3.7–4.5) years. A positive AI-ECG screen portended a 4- to 24-fold higher risk of new-onset HF [age-, sex-adjusted hazard ratio: YNHHS, 3.88 (95% confidence interval 3.63–4.14); UKB, 12.85 (6.87–24.02); ELSA-Brasil, 23.50 (11.09–49.81)]. The association was consistent after accounting for comorbidities and the competing risk of death. Higher probabilities were associated with progressively higher HF risk. Model discrimination was 0.718 in YNHHS, 0.769 in UKB, and 0.810 in ELSA-Brasil. In YNHHS and ELSA-Brasil, incorporating AI-ECG with PCP-HF yielded a significant improvement in discrimination over PCP-HF alone.

Conclusions

An AI model applied to a single ECG image defined the risk of future HF, representing a digital biomarker for stratifying HF risk.

Contributors

Arya Aminorroaya
Arya Aminorroaya

Author

Yale School of Medicine New Haven , United States of America

Folkert W Asselbergs
Folkert W Asselbergs

Author

Amsterdam University Medical Centre (AUMC) Amsterdam , Netherlands (The)

Antonio Luiz P Ribeiro
Antonio Luiz P Ribeiro

Author

Federal University of Minas Gerais Belo Horizonte , Brazil

Evangelos K Oikonomou
Evangelos K Oikonomou

Author

Yale School of Medicine New Haven , United States of America

Rohan Khera
Rohan Khera

Author

Yale School of Medicine New Haven , United States of America

ESC 365 is supported by